BCL-2 was first identified as a pro-survival oncogene in Follicular Lymphoma, where the characteristic translocation, t(14;18), couples the immunoglobulin heavy chain promotor with the BCL-2 gene [14]. The gene discussed is BCL2; the disease is follicular lymphoma.